I was wondering the same thing. If avr can submit for fda approval for viv, then surely it is recognised as a procedure in its own right. No other firm has submitted for ViV as it hasn't existed as a problem. The current approach could reasonably be called a work around rather than approved.
AVR Price at posting:
$19.80 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)